Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection

Blood

Volumn 92, Issue 6, 1998, Pages 2177-2181

  Martin, Paul J ^a   Akatsuka, Yoshiki ^b   Hahne, Michael ^b   Sale, George ^b  

^a USA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; FAS LIGAND; GRANZYME B; PERFORIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOTOXICITY; DONOR; FEMALE; GRAFT REJECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032530890     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.6.2177     Document Type: Article

References (28)

1. Martin PJ: Donor CDS cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans. J Exp Med 178:703, 1993
2. Golding H, Mizuochi T, McCarthy SA, Cleveland CA, Singer A: Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenoty pic ally identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. J Immunol 138:10, 1987
3. Lapidot T, Lubin I, Terenzi A, Faktorowich Y, Erlich P, Reisner Y: Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc NatlAcad Sci USA 87:4595, 1990
4. Martin PJ: Prevention of allogenic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. Blood 88:962, 1996
5. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S. Hengartner H, Golstein P: Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
6. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370:650, 1994
7. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K, Shinkai Y, Alt FW, Matsuzawa A, Yonehara S, Takayama H: Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity 1:357, 1994
8. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J: Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft- versus-host disease. J Exp Med 183:657, 1996
9. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994
10. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner J: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31, 1994
11. Lowin B, Beermann F, Schmidt A, Tschopp J: A null mutation in the perform gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 91:11571, 1994
12. Young JW, Steinman RM: Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J Exp Med 171:1315, 1990
13. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts. I. Grafts rejection by irradiated responder mice. J Exp Med 134:83, 1971
14. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 134:1513, 1971
15. Vallera DA, Taylor PA, Sprent J, Blazar BR: The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Transplantation 57:249, 1994
16. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348, 1995
17. Shresta S, Russell JH, Ley TJ: Mechanisms responsible for granzyme B-independent cytotoxicity. Blood 89:4085, 1997
18. Baker MB, Riley RL, Podack ER, Levy RB: Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perform function. Proc Natl Acad Sci USA 94:1366, 1997
19. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K: Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 91:4930, 1994
20. Stalder T, Hahn S, Erb P: Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152:1127, 1994
21. Ju ST, Cui H, Panka DJ, Ettinger R, Marshak-Rothstein A: Participation of target Fas protein in apoptosis pathway induced by CD4-4- Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 91:4185, 1994
22. Baker MB, Altman NH, Podack ER, Levy RB: The role of cell-mediated cytotoxicity in acute GVHD after MHC- matched allogeneic bone marrow transplantation in mice. J Exp Med 183:2645, 1996
23. Speiser DE, Bachmann MF, Frick TW, McKall-Faienza K, Griffiths E, Pfeffer K, Mak TW, Ohashi PS: TNF receptor p55 controls early acute graft-versus-host disease. J Immunol 158:5185, 1997
24. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CDS effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715, 1994
25. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CDS T cells secreting Thl or Th2 cytokines. Immunity 2:271, 1995
26. Carter LL, Dutton RW: Relative perforin- and Fas-mediated lysis in T1 and T2 CDS effector populations. J Immunol 155:1028, 1995
27. Krenger W, Snyder KM, Byon JCH, Falzarano G, Ferrara JLM: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155:585, 1995
28. Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE: Allospecific CD8+ Tc1 and Tc2 populations in graft- versus-leukemia effect and graft-ver sus-host disease. J Immunol 157:4811, 1996